The effect of plasma phosphate on the action of 1alphaOHD3 in haemodialysis patients.
D000469:Alkaline Phosphatase / Q000097:blood; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D002114:Calcinosis / Q000139:chemically induced; D002118:Calcium / Q000097:blood / Q000378:metabolism*; D006801:Humans; D006887:Hydroxycholecalciferols / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D007408:Intestinal Absorption / Q000187:drug effects; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000378:metabolism* / Q000628:therapy; D010710:Phosphates / Q000097:blood / Q000378:metabolism*; D006435:Renal Dialysis
D006887:Hydroxycholecalciferols; D010710:Phosphates; D000536:Aluminum Hydroxide; D000469:Alkaline Phosphatase; D002118:Calcium